Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.
Clinical trial NCT05777902 · TERMINATED
Trial details
- NCT number
- NCT05777902
- Sponsor
- I.R.C.C.S. Fondazione Santa Lucia
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2024-04-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.